Diseases We Treat

Duke’s Hematologic Malignancy Program treats patients with all types of cancers of the blood:

Acute Leukemias
Acute Lymphoblastic Leukemia (ALL)
Acute Myelogeneous Leukemia (AML)
Acute Non-Lymphocytic Leukemia (ANL)
Acute Promyelocytic Leukemia (APML)
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
Erythroid Leukemia
Megakaryocytic Leukemia

Chronic Leukemias
Chronic Myelogenous Leukemia (CML)
Chronic Leymphocytic Leukemia (CLL)

Myelodysplasis or Myeloproliferative Diseases
Refractory Anemia
Refractory Anemia with Ringed Siderblasts
Refractory Anemia with Excess Blasts
Chronic Myelomonocytic Leukemia (CMML or CMMoL)
Agnogenic Myeloid Metaplasia
Myelofibrosis
Essential Thrombocytosis
Polycythemia Vera

Lymphoproliferative Disorders
Non-Hodgkin’s Lymphoma (NHL)
Hodgkin’s Lymphoma (HD)
Mantle Cell Lymphoma
Follicular Lymphoma
Diffuse Large Cell Lymphoma
Post Transplant Lymphoproliferative Disorder
Viral Induced Lymphomas
Multiple Myeloma
Plasma Cell Leukemia
Waldenstrom’s Macroglobulinemia.

Other Marrow Disorders
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pure Red Cell Aplasia